EMCDDA Document library

Latvian recommendations for rational pharmacotherapy for C viral hepatitis within the framework of the drug reimbursement scheme

Original/alternative title: 
C vīrushepatīta racionālas farmakoterapijas rekomendācijas zāļu iegādes kompensācijas sistēmas ietvaros
Summary: 

These are the Latvian government's  2017 national guidelines on diagnosis and treatment of chronic hepatitis C. Theyt  do not mention people who inject drugs (PWID) specifically. A national HCV treatment registry was initiated in 2016 in paper format and since January 2017 it is operational electronically.